Split History
ETFs Holding LGND »    LGND Historical Stock Prices »
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Ligand Pharmaceuticals is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. Co. employs research technologies such as antibody discovery technologies, ion channel discovery technology, Pseudomonas fluorescens protein expression technology, formulation science and liver targeted pro-drug technologies to assist companies in their work toward securing prescription drug and biologic approvals. Co.'s collaboration partners and licensees have programs in clinical development targeting cancer, seizure, diabetes, cardiovascular disease, muscle wasting, liver disease, and kidney disease, among others. According to our LGND split history records, Ligand Pharmaceuticals has had 1 split.
LGND split history picture
Ligand Pharmaceuticals (LGND) has 1 split in our LGND split history database. The split for LGND took place on November 02, 2022. This was a 1603 for 1000 split, meaning for each 1000 shares of LGND owned pre-split, the shareholder now owned 1603 shares. For example, a 1000 share position pre-split, became a 1603 share position following the split.

When a company such as Ligand Pharmaceuticals splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.

Looking at the LGND split history from start to finish, an original position size of 1000 shares would have turned into 1603 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Ligand Pharmaceuticals shares, starting with a $10,000 purchase of LGND, presented on a split-history-adjusted basis factoring in the complete LGND split history. LGND split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 01/29/2013
End date: 01/27/2023
Start price/share: $12.59
End price/share: $70.29
Dividends collected/share: $0.00
Total return: 458.30%
Average Annual Total Return: 18.76%
Starting investment: $10,000.00
Ending investment: $55,808.70
Years: 10.00
Date Ratio
11/02/20221603 for 1000
LGND is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

LH Split History
LIFE Split History
LJPC Split History
LLY Split History
LPTN Split History
LRMR Split History
LSTA Split History
LUX Split History
LXRX Split History
MACK Split History

Also explore: LGND shares outstanding history

Email EnvelopeFree LGND Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Galway Metals Inc. (GWM.CA)
Lannett Company, Inc. (LCI)
Reed's, Inc. (REED)
Phio Pharmaceuticals Corp. (PHIO)
Swvl Holdings Corp (SWVL)
Sientra, Inc. (SIEN)
Eargo, Inc. (EAR)
Alterity Therapeutics Limited (ATHE)
Aytu BioPharma, Inc. (AYTU)
OpGen, Inc. (OPGN)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

LGND Insider Buying

LGND Split History | www.SplitHistory.com | Copyright © 2013 - 2023, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.